Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-11-27, Stock:PFE, The news for the past five days is as follows:
2018-11-19: NEWS1: Stock Market Today: Sea of Red.NEWS2: Dow, Nasdaq Clobbered as FAANG Continues to Suffer.NEWS3: Dow, Nasdaq Clobbered as FAANG Continues to Suffer.NEWS4: Pfizer (PFE) Gains As Market Dips: What You Should Know.NEWS5: Nasdaq Slides More Than 3% As These Dow Blue Chips Buck The Broad Sell-Off.NEWS6: Pfizer Shares Jump on Monday After Company Signals Higher Price Push.NEWS7: Market Close Report: NASDAQ Composite index closes at 7,028.48 down -219.39 points.NEWS8: Market Close Report: NASDAQ Composite index closes at 7,028.48 down -219.39 points.NEWS9: Pfizer to raise drug prices despite Trump’s complaints.NEWS10: Tech Selloff Could Work in Favor of Pharmaceutical Stocks.NEWS11: Pfizer's Ovarian Cancer Treatment Fails In Late-Stage Test.NEWS12: 3 Steady Healthcare Stocks to Hold During a Downturn.NEWS13: Pfizer Shares Rise Even as U.S. Lawmakers, Administration Criticize Drug Pricing.NEWS14: Pfizer, Other Pharma Stocks Should Continue to Do Well Amid Market Volatility.NEWS15: One Put, One Call Option To Know About for Pfizer.NEWS16: One Put, One Call Option To Know About for Pfizer.NEWS17: Pfizer Lifting Prices on 41 Drugs in 2019.NEWS18: Pfizer's Oncology Offerings Present Opportunity for Long-Term Stock Growth.NEWS19: Drug Pricing Resurfaces, Pfizer to Raise Cost of 41 Drugs.NEWS20: Drug Pricing Resurfaces, Pfizer to Raise Cost of 41 Drugs.NEWS21: Amgen's Blincyto Gets Positive CHMP Opinion for Line Extension.NEWS22: Amgen's Blincyto Gets Positive CHMP Opinion for Line Extension.NEWS23: Jim Cramer Reacts to Pfizer's Drug Hikes.NEWS24: Stocks - Apple Falls in Pre-market; Nissan, Renault, PG&E, JD.com Sink.NEWS25: Health Care Sector Update for 11/19/2018: SNOA, GSK, PFE, MRK, ABT, AMGN, JNJ.NEWS26: Health Care Sector Update for 11/19/2018: SNOA, GSK, PFE, MRK, ABT, AMGN, JNJ.NEWS27: Amgen's Blincyto Gets Positive CHMP Opinion for Line Extension.NEWS28: Drug Pricing Resurfaces, Pfizer to Raise Cost of 41 Drugs.NEWS29: Pfizer Stock Slides Slightly as Drug-Maker Prepares Price Increases.NEWS30: Pfizer Could Rally in the Weeks Ahead as Investors Look Beyond Today's Headline.NEWS31: The Zacks Analyst Blog Highlights: Pfizer, Cisco, Southern, SunTrust Banks and AmerisourceBergen.NEWS32: The Zacks Analyst Blog Highlights: Pfizer, Cisco, Southern, SunTrust Banks and AmerisourceBergen.NEWS33: How Is Bausch Health’s Ortho Dermatologics Performing?.NEWS34: The Zacks Analyst Blog Highlights: Pfizer, Cisco, Southern, SunTrust Banks and AmerisourceBergen.NEWS35: Merck KGaA and Pfizer say drug failed to meet primary endpoints in late-stage ovarian cancer trial.NEWS36: Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer.NEWS37: Today's Research Reports on Trending Tickers: Facebook and Pfizer.NEWS38: Carlos Ghosn, Apple, US-China Trade, Bitcoin and Pfizer - 5 Things You Must Know.NEWS39: Merck KGaA, Pfizer: JAVELIN Ovarian 200 Trial Did Not Meet Primary Endpoints.NEWS40: Merck KGaA, Pfizer: JAVELIN Ovarian 200 Trial Did Not Meet Primary Endpoints.
2018-11-20: NEWS1: Corcept Initiates Phase III Study for Cushing's Syndrome.NEWS2: Corcept Initiates Phase III Study for Cushing's Syndrome.NEWS3: Corcept Initiates Phase III Study for Cushing's Syndrome.NEWS4: [$$] Diversis Capital Buys Controlling Stake of Tempo.NEWS5: Pfizer Stock Has Risen ~20% in 2018.NEWS6: Pfizer will raise drug prices come January.NEWS7: Health Care Sector Update for 11/20/2018: ORPN, BLRX, BSX, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Health Care Sector Update for 11/20/2018: ORPN, BLRX, BSX, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Pfizer's Bavencio Phase III Study for Ovarian Cancer Fails.NEWS10: Pfizer's Bavencio Phase III Study for Ovarian Cancer Fails.NEWS11: Pfizer's Bavencio Phase III Study for Ovarian Cancer Fails.NEWS12: Pfizer and 3 Other Stock Picks From a 5-Star Growth Fund.NEWS13: Pfizer (PFE) Gains As Market Dips: What You Should Know.NEWS14: Pfizer (PFE) Gains As Market Dips: What You Should Know.NEWS15: 3 Steady Healthcare Stocks to Hold During a Downturn.NEWS16: 3 Steady Healthcare Stocks to Hold During a Downturn.
2018-11-21: NEWS1: FDA approves new blood cancer treatment from Pfizer.NEWS2: Pfizer Stock Has Multiple Positive Catalysts.NEWS3: Pfizer asks GOP Sen. Cindy Hyde-Smith for contribution refund, Facebook alum Sean Parker doesn't.NEWS4: U.S. FDA Approves DAURISMO™ (glasdegib) for Adult Patients with Newly-Diagnosed Acute Myeloid Leukemia (AML) for Whom Intensive Chemotherapy is Not an Option.NEWS5: FDA approves Pfizer's treatment for rare blood cancer.NEWS6: FDA Accepts Allergan's (AGN) sNDA for Anti-Infective Avycaz.NEWS7: FDA Accepts Allergan's (AGN) sNDA for Anti-Infective Avycaz.NEWS8: Dow Movers: JNJ, CAT.NEWS9: Dow Movers: JNJ, CAT.NEWS10: Can Deal Interest Help Tesaro Recover?.NEWS11: Can Deal Interest Help Tesaro Recover?.NEWS12: Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference.NEWS13: Health Care Sector Update for 11/21/2018: SYN, CYAD, JNJ, PFE, ABT, MRK, AMGN.NEWS14: Health Care Sector Update for 11/21/2018: SYN, CYAD, JNJ, PFE, ABT, MRK, AMGN.NEWS15: FDA Accepts Allergan's (AGN) sNDA for Anti-Infective Avycaz.NEWS16: Why Pfizer’s Share Price Fell on November 20.NEWS17: 5 Quality Blue Chips to Thrive in Bull and Bear Markets.NEWS18: [$$] Global markets retreat as tech rout spreads.
2018-11-23: NEWS1: [$$] Pharma Stocks Soothe Stock-Market Malady.NEWS2: These 3 Stocks Are Up 25% in 2018 -- Are They Still Buys?.NEWS3: Pharma Stock Roundup: Cancer Approvals for PFE & ABBV, CHMP Nod for Several Drugs.NEWS4: Pharma Stock Roundup: Cancer Approvals for PFE & ABBV, CHMP Nod for Several Drugs.NEWS5: Dow 30 Stock Roundup: Boeing to Supply 40 737 MAX 8 to Jeju Air, Pfizer Gets FDA Nod.NEWS6: Dow 30 Stock Roundup: Boeing to Supply 40 737 MAX 8 to Jeju Air, Pfizer Gets FDA Nod.NEWS7: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for November 26, 2018.NEWS8: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for November 26, 2018.NEWS9: Pharma Stock Roundup: Cancer Approvals for PFE & ABBV, CHMP Nod for Several Drugs.NEWS10: Dow 30 Stock Roundup: Boeing to Supply 40 737 MAX 8 to Jeju Air, Pfizer Gets FDA Nod.
2018-11-26: NEWS1: Google asks for refund of campaign contribution to embattled Sen. Cindy Hyde-Smith.NEWS2: Spark Therapeutics' Luxturna Gets EU Approval for Vision Loss.NEWS3: Spark Therapeutics' Luxturna Gets EU Approval for Vision Loss.NEWS4: Spark Therapeutics' Luxturna Gets EU Approval for Vision Loss.NEWS5: Interesting January 2020 Stock Options for PFE.NEWS6: Interesting January 2020 Stock Options for PFE.NEWS7: Bayer looks at options for consumer brands, animal health - sources.NEWS8: The Zacks Analyst Blog Highlights: Pfizer, AbbVie, J&J, Glaxo and AstraZeneca.NEWS9: The Zacks Analyst Blog Highlights: Pfizer, AbbVie, J&J, Glaxo and AstraZeneca.NEWS10: ATRS: Xyosted Launch Before Year End.NEWS11: Bayer discusses sale of some consumer brands, future of animal health-sources.NEWS12: The Zacks Analyst Blog Highlights: Pfizer, AbbVie, J&J, Glaxo and AstraZeneca.NEWS13: Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for November 27, 2018.NEWS14: Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for November 27, 2018.

Answer: Rise